Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 InhibitorsVindhya Udhane, Marja T. Nevalainen, Kenneth A. Iczkowski et al.|Molecular Cancer Therapeutics|2019Cited by 26
CARD-only proteins regulate in vivo inflammasome responses and ameliorate goutSavita Devi, Andrea Dorfleutner|Cell Reports|2023Cited by 17
Stat5 induces androgen receptor ( <i>AR</i> ) gene transcription in prostate cancer and offers a druggable pathway to target AR signalingCristina Maranto, Marja T. Nevalainen, Lavannya Sabharwal et al.|Science Advances|2024Cited by 10
The role of enzalutamide-induced hyperactive Jak2-Stat5 feed-forward signaling loop on enzalutamide-resistant prostate cancer growth and as a therapeutic target for second-line treatment.Vindhya Udhane, Marja T. Nevalainen, Cristina Maranto et al.|Journal of Clinical Oncology|2019Cited by 2